Medicare launches $50 Wegovy pilot with strict eligibility

Medicare launches $50 monthly Wegovy program with strict eligibility criteria

24/7 Wall St. • 29 Jul 12:03

Starting July 1, 2026, Medicare will offer a $50 copay for certain GLP-1 drugs, including Wegovy, but only beneficiaries who meet specific BMI and health-condition requirements and are enrolled in an eligible Part D plan can access the benefit.

Medicare launches $50 monthly GLP-1 weight-loss drug pilot for eligible seniors

AP News • 01 Jul 11:09

A new Medicare program will provide selected GLP-1 weight-loss medications to qualifying beneficiaries for $50 a month through 2027, with eligibility based on BMI and health conditions.

Medicare launches pilot to cover GLP-1 obesity drugs for seniors at $50 monthly

ABC News - Breaking News, Latest News and Videos • 01 Jul 09:14

A new federal pilot program will allow eligible Medicare beneficiaries to obtain GLP-1 medications for obesity at a $50 co-pay per month, beginning in July and running through the end of 2027.

Medicare launches temporary coverage for obesity drugs with $50 copay

CNBC • 30 Jun 09:00

A new Medicare demonstration program will pay for GLP-1 obesity medications for eligible seniors at a $50 monthly copayment, but the coverage is set to expire in 2027.

Medicare launches pilot program to cover GLP-1 weight-loss drugs with $50 copay

CBS News • 29 Jun 19:39

Starting July 1, Medicare will offer an 18-month pilot that pays for certain GLP-1 medications prescribed for obesity, requiring a $50 monthly copay for eligible beneficiaries.